Saturday, November 12, 2011

Abbott faces whistle-blower suits over Depakote marketing

By Ellen Gabler, Chicago Tribune reporter

November 13, 2011

Trainees were then taken to a separate room where the door was closed, and an experienced Abbott sales rep said to ignore corporate trainers' directions and instead market Depakote, an epilepsy drug, as a way to treat agitation associated with dementia, a practice that would be illegal, Thomas Spetter alleges in a whistle-blower lawsuit filed in 2010.

Posted via email from Jack's posterous

No comments: